Study designs of evaluations included in the review
Case series and randomised controlled trials (RCTs) were included.
Specific interventions included in the review
Cytotoxic chemotherapy: single-agent chemotherapy, combination chemotherapy, and interferons. In addition, adenosine analogues, retinoids, photopheresis (extracorporeal photochemotherapy), cyclosporin, monoclonal antibody therapy, immunoconjugates and interleukin-2, and miscellaneous therapies.
Participants included in the review
Patients with mycosis fungoides or the Sezary syndrome.
Outcomes assessed in the review
The objective response to treatment (complete response or partial response) was assessed.
How were decisions on the relevance of primary studies made?
The authors do not state how the papers were selected for the review, or how many of the authors performed the selection.